Alexander G Duarte1, Leon Tung1, Wei Zhang1, En Shuo Hsu2, Yong-Fang Kuo2,3, Gulshan Sharma1,3. 1. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Texas Medical Branch, Galveston. 2. Office of Biostatistics, University of Texas Medical Branch, Galveston. 3. Sealy Center of Aging, University of Texas Medical Branch, Galveston.
Abstract
OBJECTIVES: Determine the prevalence of suboptimal peak inspiratory flow rate (PIFR) and associated patient characteristics and compare PIFR measurements obtained with spirometry and In-Check DIAL® device in ambulatory patients with COPD. METHODS: Patients underwent PIFR measurement with In-Check DIAL® device and pulmonary function testing with calibrated equipment. Group characteristics and lung function were compared for patients with suboptimal (≤ 60 L/min) and optimal (> 60 L/min) PIFR. Receiver operating curve analysis determined the best maximal forced inspiratory flow (FIF max) value in identifying optimal PIFR by gender and height. RESULTS: From July 1, 2016 to January 31, 2018, a total of 303 patients with chronic obstructive pulmonary disease (COPD) had PIFR and pulmonary function measurements. Group mean age was 65.5 ± 11.3 years with equal gender distribution. Suboptimal PIFR was observed in 61 (20.1%) patients. A significant correlation was observed between PIFR and FIF max, inspiratory capacity and residual volume (RV) to total lung capacity (TLC) ratio. In the suboptimal PIFR group, mean FIF max measured by spirometry was significantly less compared with the optimal PIFR group; 178.5 ± 56.9 L/min and 263.4 ± 89.9 L/min, respectively (p<0.0001). Receiver operator curve analysis of FIF max to identify an optimal PIFR yielded an area under the curve of 0.79. Males < 65 inches had a suboptimal PIFR in 16.7 % of the male cohort, while females < 65 inches had a suboptimal PIFR in 27.4 % of the women. CONCLUSIONS: Suboptimal PIFR was present in 1 in 5 stable patients with COPD and was more frequent in short statured females. Spirometry determined FIF max was associated with PIFR based on gender and height. JCOPDF
OBJECTIVES: Determine the prevalence of suboptimal peak inspiratory flow rate (PIFR) and associated patient characteristics and compare PIFR measurements obtained with spirometry and In-Check DIAL® device in ambulatory patients with COPD. METHODS: Patients underwent PIFR measurement with In-Check DIAL® device and pulmonary function testing with calibrated equipment. Group characteristics and lung function were compared for patients with suboptimal (≤ 60 L/min) and optimal (> 60 L/min) PIFR. Receiver operating curve analysis determined the best maximal forced inspiratory flow (FIF max) value in identifying optimal PIFR by gender and height. RESULTS: From July 1, 2016 to January 31, 2018, a total of 303 patients with chronic obstructive pulmonary disease (COPD) had PIFR and pulmonary function measurements. Group mean age was 65.5 ± 11.3 years with equal gender distribution. Suboptimal PIFR was observed in 61 (20.1%) patients. A significant correlation was observed between PIFR and FIF max, inspiratory capacity and residual volume (RV) to total lung capacity (TLC) ratio. In the suboptimal PIFR group, mean FIF max measured by spirometry was significantly less compared with the optimal PIFR group; 178.5 ± 56.9 L/min and 263.4 ± 89.9 L/min, respectively (p<0.0001). Receiver operator curve analysis of FIF max to identify an optimal PIFR yielded an area under the curve of 0.79. Males < 65 inches had a suboptimal PIFR in 16.7 % of the male cohort, while females < 65 inches had a suboptimal PIFR in 27.4 % of the women. CONCLUSIONS: Suboptimal PIFR was present in 1 in 5 stable patients with COPD and was more frequent in short statured females. Spirometry determined FIF max was associated with PIFR based on gender and height. JCOPDF
Authors: J Wanger; J L Clausen; A Coates; O F Pedersen; V Brusasco; F Burgos; R Casaburi; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D Johnson; N Macintyre; R McKay; M R Miller; D Navajas; R Pellegrino; G Viegi Journal: Eur Respir J Date: 2005-09 Impact factor: 16.671
Authors: Myrna B Dolovich; Richard C Ahrens; Dean R Hess; Paula Anderson; Rajiv Dhand; Joseph L Rau; Gerald C Smaldone; Gordon Guyatt Journal: Chest Date: 2005-01 Impact factor: 9.410
Authors: Rajiv Dhand; Donald A Mahler; Brian W Carlin; Nicola A Hanania; Jill A Ohar; Victor Pinto-Plata; Tina Shah; David Eubanks; Sidney S Braman Journal: Respir Care Date: 2018-03-20 Impact factor: 2.258
Authors: Brendan Clark; Brian J Wells; Amit K Saha; Jessica Franchino-Elder; Asif Shaikh; Bonnie M K Donato; Jill A Ohar Journal: Int J Chron Obstruct Pulmon Dis Date: 2022-06-29
Authors: L Pekka Malmberg; Anna S Pelkonen; Ville Vartiainen; Mikko Vahteristo; Satu Lähelmä; Rain Jõgi Journal: J Thorac Dis Date: 2021-02 Impact factor: 3.005
Authors: Jill A Ohar; Gary T Ferguson; Donald A Mahler; M Bradley Drummond; Rajiv Dhand; Roy A Pleasants; Antonio Anzueto; David M G Halpin; David B Price; Gail S Drescher; Haley M Hoy; John Haughney; Michael W Hess; Omar S Usmani Journal: Int J Chron Obstruct Pulmon Dis Date: 2022-01-06
Authors: Marika Leving; Hans Wouters; Alberto de la Hoz; Sinthia Bosnic-Anticevich; Richard Dekhuijzen; Asparuh Gardev; Federico Lavorini; Jiska Meijer; David Price; Miguel Román Rodríguez; Ioanna Tsiligianni; Omar Usmani; Birgit Wijnsma; Janwillem Kocks Journal: Pulm Ther Date: 2021-09-17